메뉴 건너뛰기




Volumn 2011, Issue , 2011, Pages

Pharmacological treatment of obesity in patients with polycystic ovary syndrome

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84869880616     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2011/402052     Document Type: Article
Times cited : (9)

References (70)
  • 1
    • 2942642477 scopus 로고    scopus 로고
    • The prevalence and features of the polycystic ovary syndrome in an unselected population
    • DOI 10.1210/jc.2003-032046
    • Azziz R., Woods K. S., Reyna R., Key T. J., Knochenhauer E. S., Yildiz B. O., The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2745 2749 2-s2.0-2942642477 10.1210/jc.2003-032046 (Pubitemid 38766360)
    • (2004) Journal of Clinical Endocrinology and Metabolism , vol.89 , Issue.6 , pp. 2745-2749
    • Azziz, R.1    Woods, K.S.2    Reyna, R.3    Key, T.J.4    Knochenhauer, E.S.5    Yildiz, B.O.6
  • 2
    • 0031773509 scopus 로고    scopus 로고
    • Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: A prospective study
    • DOI 10.1210/jc.83.9.3078
    • Knochenhauer E. S., Key T. J., Kahsar-Miller M., Waggoner W., Boots L. R., Azziz R., Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study. Journal of Clinical Endocrinology and Metabolism 1998 83 9 3078 3082 2-s2.0-0031773509 10.1210/jc.83.9.3078 (Pubitemid 28500937)
    • (1998) Journal of Clinical Endocrinology and Metabolism , vol.83 , Issue.9 , pp. 3078-3082
    • Knochenhauer, E.S.1    Key, T.J.2    Kahsar-Miller, M.3    Waggoner, W.4    Boots, L.R.5    Azziz, R.6
  • 4
    • 0034457559 scopus 로고    scopus 로고
    • A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain
    • DOI 10.1210/jc.85.7.2434
    • Asunción M., Calvo R. M., San Millá N J. L., Sancho J., Avila S., Escobar-Morreale H. F., A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism 2000 85 7 2434 2438 2-s2.0-0034457559 10.1210/jc.85.7.2434 (Pubitemid 32269197)
    • (2000) Journal of Clinical Endocrinology and Metabolism , vol.85 , Issue.7 , pp. 2434-2438
    • Asuncion, M.1    Calvo, R.M.2    San Milla N, J.L.3    Sancho, J.4    Avila, S.5    Escobar-Morreale, H.F.6
  • 6
    • 26444434868 scopus 로고    scopus 로고
    • Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy
    • DOI 10.1016/j.ejogrb.2005.03.010, PII S0301211505001429
    • Glueck C. J., Dharashivkar S., Wang P., Zhu B., Gartside P. S., Tracy T., Sieve L., Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy. European Journal of Obstetrics Gynecology and Reproductive Biology 2005 122 2 206 212 2-s2.0-26444434868 10.1016/j.ejogrb.2005.03.010 (Pubitemid 41430458)
    • (2005) European Journal of Obstetrics Gynecology and Reproductive Biology , vol.122 , Issue.2 , pp. 206-212
    • Glueck, C.J.1    Dharashivkar, S.2    Wang, P.3    Zhu, B.4    Gartside, P.S.5    Tracy, T.6    Sieve, L.7
  • 9
    • 33644829109 scopus 로고    scopus 로고
    • Diagnosis of polycystic ovarian syndrome: In defense of the Rotterdam criteria
    • DOI 10.1210/jc.2005-2501
    • Franks S., Diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. Journal of Clinical Endocrinology and Metabolism 2006 91 3 786 789 2-s2.0-33644829109 10.1210/jc.2005-2501 (Pubitemid 43357737)
    • (2006) Journal of Clinical Endocrinology and Metabolism , vol.91 , Issue.3 , pp. 786-789
    • Franks, S.1
  • 10
    • 0024437305 scopus 로고
    • Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
    • Dunaif A., Segal K. R., Futterweit W., Dobrjansky A., Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989 38 9 1165 1174 2-s2.0-0024437305 (Pubitemid 19250404)
    • (1989) Diabetes , vol.38 , Issue.9 , pp. 1165-1174
    • Dunaif, A.1    Segal, K.R.2    Futterweit, W.3    Dobrjansky, A.4
  • 11
    • 0028787490 scopus 로고
    • A novel serum protein similar to C1q, produced exclusively in adipocytes
    • 2-s2.0-0028787490 10.1074/jbc.270.45.26746
    • Scherer P. E., Williams S., Fogliano M., Baldini G., Lodish H. F., A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological Chemistry 1995 270 45 26746 26749 2-s2.0-0028787490 10.1074/jbc.270.45.26746
    • (1995) Journal of Biological Chemistry , vol.270 , Issue.45 , pp. 26746-26749
    • Scherer, P.E.1    Williams, S.2    Fogliano, M.3    Baldini, G.4    Lodish, H.F.5
  • 13
    • 77749270628 scopus 로고    scopus 로고
    • High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance
    • 2-s2.0-77749270628 10.1210/jc.2009-1557
    • O'Connor A., Phelan N., Kyaw Tun T., Boran G., Gibney J., Roche H. M., High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. Journal of Clinical Endocrinology and Metabolism 2010 95 3 1378 1385 2-s2.0-77749270628 10.1210/jc.2009-1557
    • (2010) Journal of Clinical Endocrinology and Metabolism , vol.95 , Issue.3 , pp. 1378-1385
    • O'Connor, A.1    Phelan, N.2    Kyaw Tun, T.3    Boran, G.4    Gibney, J.5    Roche, H.M.6
  • 14
    • 0034999667 scopus 로고    scopus 로고
    • Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia
    • DOI 10.1210/jc.86.5.1930
    • Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R. E., Tataranni P. A., Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 2001 86 5 1930 1935 2-s2.0-0034999667 10.1210/jc.86.5.1930 (Pubitemid 32472900)
    • (2001) Journal of Clinical Endocrinology and Metabolism , vol.86 , Issue.5 , pp. 1930-1935
    • Weyer, C.1    Funahashi, T.2    Tanaka, S.3    Hotta, K.4    Matsuzawa, Y.5    Pratley, R.E.6    Tataranni, P.A.7
  • 15
    • 0033586747 scopus 로고    scopus 로고
    • The role of leptin in human obesity and disease: A review of current evidence
    • Mantzoros C. S., The role of leptin in human obesity and disease: a review of current evidence. Annals of Internal Medicine 1999 130 8 671 680 2-s2.0-0033586747 (Pubitemid 29196202)
    • (1999) Annals of Internal Medicine , vol.130 , Issue.8 , pp. 671-680
    • Mantzoros, C.S.1
  • 17
    • 33747633975 scopus 로고    scopus 로고
    • Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls
    • DOI 10.1530/eje.1.02207
    • Glintborg D., Andersen M., Hagen C., Frystyk J., Hulstrøm V., Flyvbjerg A., Hermann A. P., Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. European Journal of Endocrinology 2006 155 2 337 345 2-s2.0-33747633975 10.1530/eje.1.02207 (Pubitemid 44269452)
    • (2006) European Journal of Endocrinology , vol.155 , Issue.2 , pp. 337-345
    • Glintborg, D.1    Andersen, M.2    Hagen, C.3    Frystyk, J.4    Hulstrom, V.5    Flyvbjerg, A.6    Hermann, A.P.7
  • 18
    • 39149085035 scopus 로고    scopus 로고
    • Serum levels of leptin and homocysteine in women with polycystic ovary syndrome and its relationship to endocrine, clinical and metabolic parameters
    • Atamar A., Demir B., Bayhan G., Atamer Y., Ilhan N., Akkuş Z., Serum levels of leptin and homocysteine in women with polycystic ovary syndrome and its relationship to endocrine, clinical and metabolic parameters. Journal of International Medical Research 2008 36 1 96 105 2-s2.0-39149085035 (Pubitemid 351255975)
    • (2008) Journal of International Medical Research , vol.36 , Issue.1 , pp. 96-105
    • Atamar, A.1    Demir, B.2    Bayhan, G.3    Atamer, Y.4    Ilhan, N.5    Akkus, Z.6
  • 19
    • 36849071397 scopus 로고    scopus 로고
    • Association of serum and follicular fluid leptin concentrations with granulosa cell phosphorylated signal transducer and activator of transcription 3 expression in fertile patients with polycystic ovarian syndrome
    • DOI 10.1210/jc.2007-0978
    • Li M. G., Ding G. L., Chen XI. J., Lu XI. P., Dong LI. J., Dong M. Y., Yang X. F., Lu X. E., Huang H. F., Association of serum and follicular fluid leptin concentrations with granulosa cell phosphorylated signal transducer and activator of transcription 3 expression in fertile patients with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 2007 92 12 4771 4776 2-s2.0-36849071397 10.1210/jc.2007-0978 (Pubitemid 350223459)
    • (2007) Journal of Clinical Endocrinology and Metabolism , vol.92 , Issue.12 , pp. 4771-4776
    • Li, M.-G.1    Ding, G.-L.2    Chen, X.-J.3    Lu, X.-P.4    Dong, L.-J.5    Dong, M.-Y.6    Yang, X.-F.7    Lu, X.-E.8    Huang, H.-F.9
  • 21
    • 33645048165 scopus 로고    scopus 로고
    • Adipokine resistin promotes in vitro angiogenesis of human endothelial cells
    • 2-s2.0-33645048165 10.1016/j.cardiores.2006.01.015
    • Mu H., Ohashi R., Yan S., Chai H., Yang H., Lin P., Yao Q., Chen C., Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovascular Research 2006 70 1 146 157 2-s2.0-33645048165 10.1016/j.cardiores.2006.01.015
    • (2006) Cardiovascular Research , vol.70 , Issue.1 , pp. 146-157
    • Mu, H.1    Ohashi, R.2    Yan, S.3    Chai, H.4    Yang, H.5    Lin, P.6    Yao, Q.7    Chen, C.8
  • 22
    • 54749114466 scopus 로고    scopus 로고
    • It's not how fat you are, it's what you do with it that counts
    • ARTICLE E237 2-s2.0-54749114466 10.1371/journal.pbio.0060237
    • Virtue S., Vidal-Puig A., It's not how fat you are, it's what you do with it that counts. PLoS Biology 2008 6 9, article e237 2-s2.0-54749114466 10.1371/journal.pbio.0060237
    • (2008) PLoS Biology , vol.6 , Issue.9
    • Virtue, S.1    Vidal-Puig, A.2
  • 23
    • 72049087477 scopus 로고    scopus 로고
    • Adipose tissue expandability and the early origins of PCOS
    • 2-s2.0-72049087477 10.1016/j.tem.2009.06.003
    • de Zegher F., Lopez-Bermejo A., Ibáñez L., Adipose tissue expandability and the early origins of PCOS. Trends in Endocrinology and Metabolism 2009 20 9 418 423 2-s2.0-72049087477 10.1016/j.tem.2009.06.003
    • (2009) Trends in Endocrinology and Metabolism , vol.20 , Issue.9 , pp. 418-423
    • De Zegher, F.1    Lopez-Bermejo, A.2    Ibáñez, L.3
  • 24
    • 0029079779 scopus 로고
    • Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups
    • 2-s2.0-0029079779
    • Meirow D., Yossepowitch O., Rosler A., Brzezinski A., Schenker J. G., Laufer N., Raz I., Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups. Human Reproduction 1995 10 8 1951 1956 2-s2.0-0029079779
    • (1995) Human Reproduction , vol.10 , Issue.8 , pp. 1951-1956
    • Meirow, D.1    Yossepowitch, O.2    Rosler, A.3    Brzezinski, A.4    Schenker, J.G.5    Laufer, N.6    Raz, I.7
  • 25
    • 0344286476 scopus 로고    scopus 로고
    • Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome
    • DOI 10.2337/diacare.22.1.141
    • Ehrmann D. A., Cavaghan M. K., Barnes R. B., Imperial J., Rosenfield R. L., Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999 22 1 141 146 2-s2.0-0344286476 10.2337/diacare.22.1.141 (Pubitemid 29028311)
    • (1999) Diabetes Care , vol.22 , Issue.1 , pp. 141-146
    • Ehrmann, D.A.1    Cavaghan, M.K.2    Barnes, R.B.3    Imperial, J.4    Rosenfield, R.L.5
  • 28
    • 67349217369 scopus 로고    scopus 로고
    • Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects
    • 2-s2.0-67349217369 10.1016/j.atherosclerosis.2008.09.010
    • Rajendran S., Willoughby S. R., Chan W. P. A., Liberts E. A., Heresztyn T., Saha M., Marber M. S., Norman R. J., Horowitz J. D., Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis 2009 204 2 509 514 2-s2.0-67349217369 10.1016/j.atherosclerosis.2008.09.010
    • (2009) Atherosclerosis , vol.204 , Issue.2 , pp. 509-514
    • Rajendran, S.1    Willoughby, S.R.2    Chan, W.P.A.3    Liberts, E.A.4    Heresztyn, T.5    Saha, M.6    Marber, M.S.7    Norman, R.J.8    Horowitz, J.D.9
  • 29
    • 0027080247 scopus 로고
    • Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women
    • Dahlgren E., Janson P. O., Johansson S., Lapidus L., Oden A., Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women. Acta Obstetricia et Gynecologica Scandinavica 1992 71 8 599 604 2-s2.0-0027080247 (Pubitemid 23050339)
    • (1992) Acta Obstetricia et Gynecologica Scandinavica , vol.71 , Issue.8 , pp. 599-604
    • Dahlgren, E.1    Janson, P.O.2    Johansson, S.3    Lapidus, L.4    Oden, A.5
  • 30
    • 0034078044 scopus 로고    scopus 로고
    • Cardiovascular disease in women with polycystic ovary syndrome at long- term follow-up: A retrospective cohort study
    • DOI 10.1046/j.1365-2265.2000.01000.x
    • Wild S., Pierpoint T., McKeigue P., Jacobs H., Cardiovascular disease in women with polycystic ovary syndrome at long- term follow-up: a retrospective cohort study. Clinical Endocrinology 2000 52 5 595 600 2-s2.0-0034078044 10.1046/j.1365-2265.2000.01000.x (Pubitemid 30337085)
    • (2000) Clinical Endocrinology , vol.52 , Issue.5 , pp. 595-600
    • Wild, S.1    Pierpoint, T.2    McKeigue, P.3    Jacobs, H.4
  • 31
    • 42049083794 scopus 로고    scopus 로고
    • Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored women's ischemia syndrome evaluation
    • DOI 10.1210/jc.2007-0425
    • Shaw L. J., Merz C. N. B., Azziz R., Stanczyk F. Z., Sopko G., Braunstein G. D., Kelsey S. F., Kip K. E., Cooper-DeHoff R. M., Johnson B. D., Vaccarino V., Reis S. E., Bittner V., Hodgson T. K., Rogers W., Pepine C. J., Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored women's ischemia syndrome evaluation. Journal of Clinical Endocrinology and Metabolism 2008 93 4 1276 1284 2-s2.0-42049083794 10.1210/jc.2007-0425 (Pubitemid 351519721)
    • (2008) Journal of Clinical Endocrinology and Metabolism , vol.93 , Issue.4 , pp. 1276-1284
    • Shaw, L.J.1    Merz, C.N.B.2    Azziz, R.3    Stanczyk, F.Z.4    Sopko, G.5    Braunstein, G.D.6    Kelsey, S.F.7    Kip, K.E.8    Cooper-DeHoff, R.M.9    Johnson, B.D.10    Vaccarino, V.11    Reis, S.E.12    Bittner, V.13    Hodgson, T.K.14    Rogers, W.15    Pepine, C.J.16
  • 32
    • 17844367331 scopus 로고    scopus 로고
    • Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome
    • DOI 10.1210/jc.2004-1045
    • Apridonidze T., Essah P. A., Iuorno M. J., Nestler J. E., Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2005 90 4 1929 1935 2-s2.0-17844367331 10.1210/jc.2004-1045 (Pubitemid 40586223)
    • (2005) Journal of Clinical Endocrinology and Metabolism , vol.90 , Issue.4 , pp. 1929-1935
    • Apridonidze, T.1    Essah, P.A.2    Iuorno, M.J.3    Nestler, J.E.4
  • 33
    • 0029064786 scopus 로고
    • Body fat distribution in women with polycystic ovary syndrome
    • 2-s2.0-0029064786 10.1016/0029-7844(95)00250-U
    • Douchi T., Ijuin H., Nakamura S., Oki T., Yamamoto S., Nagata Y., Body fat distribution in women with polycystic ovary syndrome. Obstetrics and Gynecology 1995 86 4, part 1 516 519 2-s2.0-0029064786 10.1016/0029-7844(95) 00250-U
    • (1995) Obstetrics and Gynecology , vol.86 , Issue.4 PART 1 , pp. 516-519
    • Douchi, T.1    Ijuin, H.2    Nakamura, S.3    Oki, T.4    Yamamoto, S.5    Nagata, Y.6
  • 34
    • 0033168295 scopus 로고    scopus 로고
    • Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: A heterogeneous group of disorders
    • DOI 10.1016/S0015-0282(99)00184-3, PII S0015028299001843
    • Acien P., Quereda F., Matallin P., Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertility and Sterility 1999 72 1 32 40 10.1016/S0015-0282(99)00184-3 (Pubitemid 29300258)
    • (1999) Fertility and Sterility , vol.72 , Issue.1 , pp. 32-40
    • Quereda, F.1    Villarroya, E.2    Lopez-Fernandez, J.A.3    Alfayate, R.4
  • 35
    • 33750333937 scopus 로고    scopus 로고
    • Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women
    • DOI 10.1001/archinte.166.19.2081
    • Álvarez-Blasco F., Botella-Carretero J. I., San Millán J. L., Escobar-Morreale H. F., Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Archives of Internal Medicine 2006 166 19 2081 2086 2-s2.0-33750333937 10.1001/archinte.166.19.2081 (Pubitemid 44631395)
    • (2006) Archives of Internal Medicine , vol.166 , Issue.19 , pp. 2081-2086
    • Alvarez-Blasco, F.1    Botella-Carretero, J.I.2    San Millan, J.L.3    Escobar-Morreale, H.F.4
  • 36
    • 38149096151 scopus 로고    scopus 로고
    • Impact of obesity on the risk for polycystic ovary syndrome
    • 2-s2.0-38149096151 10.1210/jc.2007-1834
    • Yildiz B. O., Knochenhauer E. S., Azziz R., Impact of obesity on the risk for polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2008 93 1 162 168 2-s2.0-38149096151 10.1210/jc.2007-1834
    • (2008) Journal of Clinical Endocrinology and Metabolism , vol.93 , Issue.1 , pp. 162-168
    • Yildiz, B.O.1    Knochenhauer, E.S.2    Azziz, R.3
  • 38
    • 0033346579 scopus 로고    scopus 로고
    • Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: Role of insulin sensitivity and luteinizing hormone
    • Huber-Buchholz M. M., Carey D. G. P., Norman R. J., Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. Journal of Clinical Endocrinology and Metabolism 1999 84 4 1470 1474 2-s2.0-0033346579 (Pubitemid 30644417)
    • (1999) Journal of Clinical Endocrinology and Metabolism , vol.84 , Issue.4 , pp. 1470-1474
    • Huber-Buchholz, M.-M.1    Carey, D.G.P.2    Norman, R.J.3
  • 39
    • 33747405119 scopus 로고    scopus 로고
    • Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome
    • Moran L. J., Noakes M., Clifton P. M., Wittert G. A., Williams G., Norman R. J., Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome. American Journal of Clinical Nutrition 2006 84 1 77 87 2-s2.0-33747405119 (Pubitemid 44699174)
    • (2006) American Journal of Clinical Nutrition , vol.84 , Issue.1 , pp. 77-87
    • Moran, L.J.1    Noakes, M.2    Clifton, P.M.3    Wittert, G.A.4    Williams, G.5    Norman, R.J.6
  • 40
    • 0029142760 scopus 로고
    • Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome
    • Holte J., Bergh T., Berne C., Wide L., Lithell H., Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1995 80 9 2586 2593
    • (1995) Journal of Clinical Endocrinology and Metabolism , vol.80 , Issue.9 , pp. 2586-2593
    • Holte, J.1    Bergh, T.2    Berne, C.3    Wide, L.4    Lithell, H.5
  • 41
    • 0242577363 scopus 로고    scopus 로고
    • Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome
    • DOI 10.1016/S0015-0282(03)02162-9
    • Sabuncu T., Harma M., Harma M., Nazligul Y., Kilic F., Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome. Fertility and Sterility 2003 80 5 1199 1204 2-s2.0-0242577363 10.1016/S0015-0282(03)02162-9 (Pubitemid 37377751)
    • (2003) Fertility and Sterility , vol.80 , Issue.5 , pp. 1199-1204
    • Sabuncu, T.1    Harma, M.2    Harma, M.3    Nazligul, Y.4    Kilic, F.5
  • 42
    • 55949087098 scopus 로고    scopus 로고
    • A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): A randomized open-label parallel study
    • 2-s2.0-55949087098 10.1111/j.1365-2265.2008.03260.x
    • Sathyapalan T., Cho LI. W., Kilpatrick E. S., Coady A. M., Atkin S. L., A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study. Clinical Endocrinology 2008 69 6 931 935 2-s2.0-55949087098 10.1111/j.1365-2265.2008.03260.x
    • (2008) Clinical Endocrinology , vol.69 , Issue.6 , pp. 931-935
    • Sathyapalan, T.1    Cho II, W.2    Kilpatrick, E.S.3    Coady, A.M.4    Atkin, S.L.5
  • 43
    • 0030952712 scopus 로고    scopus 로고
    • Mode of action of orlistat
    • Guerciolini R., Mode of action of orlistat. International Journal of Obesity 1997 21 supplement 3 S12 S23 (Pubitemid 27271984)
    • (1997) International Journal of Obesity , vol.21 , Issue.SUPPL. 3
    • Guerciolini, R.1
  • 44
    • 0346250180 scopus 로고    scopus 로고
    • Long-term pharmacotherapy for overweight and obesity: A systematic review and meta-analysis of randomized controlled trials
    • DOI 10.1038/sj.ijo.0802475
    • Padwal R., rpadwal@yahoo.com Li S. K., Lau D. C. W., Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. International Journal of Obesity 2003 27 12 1437 1446 10.1038/sj.ijo.0802475 (Pubitemid 38019154)
    • (2003) International Journal of Obesity , vol.27 , Issue.12 , pp. 1437-1446
    • Padwal, R.1    Li, S.K.2    Lau, D.C.W.3
  • 45
    • 1042303480 scopus 로고    scopus 로고
    • XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients
    • DOI 10.2337/diacare.27.1.155
    • Torgerson J. S., Hauptman J., Boldrin M. N., Sjöström L., XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004 27 1 155 161 2-s2.0-1042303480 10.2337/diacare.27.1.155 (Pubitemid 38196725)
    • (2004) Diabetes Care , vol.27 , Issue.1 , pp. 155-161
    • Torgerson, J.S.1    Hauptman, J.2    Boldrin, M.N.3    Sjostrom, L.4
  • 46
    • 14044255980 scopus 로고    scopus 로고
    • Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome
    • DOI 10.1210/jc.2004-0176
    • Jayagopal V., Kilpatrick E. S., Holding S., Jennings P. E., Atkin S. L., Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 2005 90 2 729 733 2-s2.0-14044255980 10.1210/jc.2004-0176 (Pubitemid 40279187)
    • (2005) Journal of Clinical Endocrinology and Metabolism , vol.90 , Issue.2 , pp. 729-733
    • Jayagopal, V.1    Kilpatrick, E.S.2    Holding, S.3    Jennings, P.E.4    Atkin, S.L.5
  • 47
    • 58549097078 scopus 로고    scopus 로고
    • Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome
    • 2-s2.0-58549097078 10.1111/j.1365-2265.2008.03309.x
    • Cho L. W., Kilpatrick E. S., Keevil B. G., Coady A. M., Atkin S. L., Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome. Clinical Endocrinology 2009 70 2 233 237 2-s2.0-58549097078 10.1111/j.1365-2265.2008. 03309.x
    • (2009) Clinical Endocrinology , vol.70 , Issue.2 , pp. 233-237
    • Cho, L.W.1    Kilpatrick, E.S.2    Keevil, B.G.3    Coady, A.M.4    Atkin, S.L.5
  • 48
    • 33845625310 scopus 로고    scopus 로고
    • Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome
    • DOI 10.1111/j.1365-2265.2006.02693.x
    • Diamanti-Kandarakis E., Katsikis I., Piperi C., Alexandraki K., Panidis D., Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome. Clinical Endocrinology 2007 66 1 103 109 2-s2.0-33845625310 10.1111/j.1365-2265.2006.02693.x (Pubitemid 44952501)
    • (2007) Clinical Endocrinology , vol.66 , Issue.1 , pp. 103-109
    • Diamanti-Kandarakis, E.1    Katsikis, I.2    Piperi, C.3    Alexandraki, K.4    Panidis, D.5
  • 49
    • 75149162547 scopus 로고    scopus 로고
    • Metformin: An old medication of new fashion: Evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
    • 2-s2.0-75149162547 10.1530/EJE-09-0733
    • Diamanti-Kandarakis E., Christakou C. D., Kandaraki E., Economou F. N., Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. European Journal of Endocrinology 2010 162 2 193 212 2-s2.0-75149162547 10.1530/EJE-09-0733
    • (2010) European Journal of Endocrinology , vol.162 , Issue.2 , pp. 193-212
    • Diamanti-Kandarakis, E.1    Christakou, C.D.2    Kandaraki, E.3    Economou, F.N.4
  • 50
    • 0347933028 scopus 로고    scopus 로고
    • Metformin Hydrochloride in the Treatment of Type 2 Diabetes Mellitus: A Clinical Review with a Focus on Dual Therapy
    • DOI 10.1016/S0149-2918(03)90089-0
    • Setter S. M., Iltz J. L., Thams J., Campbell R. K., Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy. Clinical Therapeutics 2003 25 12 2991 3026 2-s2.0-0347933028 10.1016/S0149-2918(03)90089-0 (Pubitemid 38096142)
    • (2003) Clinical Therapeutics , vol.25 , Issue.12 , pp. 2991-3026
    • Setter, S.M.1    Iltz, J.L.2    Thams, J.3    Campbell, R.K.4
  • 51
    • 0036170744 scopus 로고    scopus 로고
    • Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial
    • DOI 10.1210/jc.87.2.569
    • Fleming R., Hopkinson Z. E., Michael Wallace A., Greer I. A., Sattar N., Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 2002 87 2 569 574 2-s2.0-0036170744 10.1210/jc.87.2.569 (Pubitemid 34158220)
    • (2002) Journal of Clinical Endocrinology and Metabolism , vol.87 , Issue.2 , pp. 569-574
    • Fleming, R.1    Hopkinson, Z.E.2    Michael Wallace, A.3    Greer, I.A.4    Sattar, N.5
  • 52
    • 0034458234 scopus 로고    scopus 로고
    • Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation
    • DOI 10.1210/jc.85.1.139
    • Moghetti P., Castello R., Negri C., Tosi F., Perrone F., Caputo M., Zanolin E., Muggeo M., Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. Journal of Clinical Endocrinology and Metabolism 2000 85 1 139 146 2-s2.0-0034458234 10.1210/jc.85.1.139 (Pubitemid 32268804)
    • (2000) Journal of Clinical Endocrinology and Metabolism , vol.85 , Issue.1 , pp. 139-146
    • Moghetti, P.1    Castello, R.2    Negri, C.3    Tosi, F.4    Perrone, F.5    Caputo, M.6    Zanolin, E.7    Muggeo, M.8
  • 53
    • 42949103243 scopus 로고    scopus 로고
    • Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: A randomized, double-blinded, placebo-controlled cross-over trial
    • DOI 10.1093/humrep/dem271
    • Trolle B., Flyvbjerg A., Kesmodel U., Lauszus F. F., Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial. Human Reproduction 2007 22 11 2967 2973 2-s2.0-42949103243 10.1093/humrep/dem271 (Pubitemid 351696807)
    • (2007) Human Reproduction , vol.22 , Issue.11 , pp. 2967-2973
    • Trolle, B.1    Flyvbjerg, A.2    Kesmodel, U.3    Lauszus, F.F.4
  • 54
    • 0142247208 scopus 로고    scopus 로고
    • Metformin in polycystic ovary syndrome: Systematic review and meta-analysis
    • Lord J. M., Flight I. H. K., Norman R. J., Metformin in polycystic ovary syndrome: systematic review and meta-analysis. British Medical Journal 2003 327 7421 951 955 2-s2.0-0142247208 (Pubitemid 37330397)
    • (2003) British Medical Journal , vol.327 , Issue.7421 , pp. 951-955
    • Lord, J.M.1    Flight, I.H.K.2    Norman, R.J.3
  • 55
    • 1242306504 scopus 로고    scopus 로고
    • Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin
    • DOI 10.1016/j.fertnstert.2003.08.012
    • Maciel G. A. R., Soares J. M., Alves Da Motta E. L., Haidar M. A., Rodrigues De Lima G., Baracat E. C., Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin. Fertility and Sterility 2004 81 2 355 360 2-s2.0-1242306504 10.1016/j.fertnstert.2003.08. 012 (Pubitemid 38223916)
    • (2004) Fertility and Sterility , vol.81 , Issue.2 , pp. 355-360
    • Maciel, G.A.R.1    Soares Jr., J.M.2    Alves Da Motta, E.L.3    Haidar, M.A.4    Rodrigues De Lima, G.5    Baracat, E.C.6
  • 56
    • 23844436916 scopus 로고    scopus 로고
    • Metformin and weight loss in obese women with polycystic ovary syndrome: Comparison of doses
    • DOI 10.1210/jc.2004-2283
    • Harborne L. R., Sattar N., Norman J. E., Fleming R., Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses. Journal of Clinical Endocrinology and Metabolism 2005 90 8 4593 4598 2-s2.0-23844436916 10.1210/jc.2004-2283 (Pubitemid 41159348)
    • (2005) Journal of Clinical Endocrinology and Metabolism , vol.90 , Issue.8 , pp. 4593-4598
    • Harborne, L.R.1    Sattar, N.2    Norman, J.E.3    Fleming, R.4
  • 57
    • 58149164733 scopus 로고    scopus 로고
    • Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS)
    • 2-s2.0-58149164733 10.1111/j.1365-2265.2008.03345.x
    • Sathyapalan T., Cho L. W., Kilpatrick E. S., Coady A. M., Atkin S. L., Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS). Clinical Endocrinology 2009 70 1 124 128 2-s2.0-58149164733 10.1111/j.1365-2265.2008. 03345.x
    • (2009) Clinical Endocrinology , vol.70 , Issue.1 , pp. 124-128
    • Sathyapalan, T.1    Cho, L.W.2    Kilpatrick, E.S.3    Coady, A.M.4    Atkin, S.L.5
  • 58
    • 0032985166 scopus 로고    scopus 로고
    • A risk-benefit assessment of metformin in type 2 diabetes mellitus
    • DOI 10.2165/00002018-199920060-00003
    • Howlett H. C. S., Bailey C. J., A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Safety 1999 20 6 489 503 2-s2.0-0032985166 10.2165/00002018-199920060-00003 (Pubitemid 29296595)
    • (1999) Drug Safety , vol.20 , Issue.6 , pp. 489-503
    • Howlett, H.C.S.1    Bailey, C.J.2
  • 59
    • 0347990354 scopus 로고    scopus 로고
    • Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2
    • DOI 10.1139/y03-107
    • Brubaker P. L., Anini Y., Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Canadian Journal of Physiology and Pharmacology 2003 81 11 1005 1012 2-s2.0-0347990354 10.1139/y03-107 (Pubitemid 38045829)
    • (2003) Canadian Journal of Physiology and Pharmacology , vol.81 , Issue.11 , pp. 1005-1012
    • Brubaker, P.L.1    Anini, Y.2
  • 60
    • 33644618433 scopus 로고    scopus 로고
    • The biology of incretin hormones
    • 2-s2.0-33644618433 10.1016/j.cmet.2006.01.004
    • Drucker D. J., The biology of incretin hormones. Cell Metabolism 2006 3 3 153 165 2-s2.0-33644618433 10.1016/j.cmet.2006.01.004
    • (2006) Cell Metabolism , vol.3 , Issue.3 , pp. 153-165
    • Drucker, D.J.1
  • 61
    • 34547684649 scopus 로고    scopus 로고
    • Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on β-cell function in normal living conditions
    • DOI 10.2337/dc07-0310
    • Mari A., Degn K., Brock B., Rungby J., Ferrannini E. L. E., Schmitz O., Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on β -cell function in normal living conditions. Diabetes Care 2007 30 8 2032 2033 2-s2.0-34547684649 10.2337/dc07-0310 (Pubitemid 47219415)
    • (2007) Diabetes Care , vol.30 , Issue.8 , pp. 2032-2033
    • Mari, A.1    Degn, K.2    Brock, B.3    Rungby, J.4    Ferrannini, E.L.E.5    Schmitz, O.6
  • 62
    • 0030068620 scopus 로고    scopus 로고
    • Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: Effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients
    • 2-s2.0-0030068620
    • Willms B., Werner J., Holst J. J., Ørskov C., Creutzfeldt W., Nauck M. A., Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients. Journal of Clinical Endocrinology and Metabolism 1996 81 1 327 332 2-s2.0-0030068620
    • (1996) Journal of Clinical Endocrinology and Metabolism , vol.81 , Issue.1 , pp. 327-332
    • Willms, B.1    Werner, J.2    Holst, J.J.3    Ørskov, C.4    Creutzfeldt, W.5    Nauck, M.A.6
  • 63
    • 0034951506 scopus 로고    scopus 로고
    • The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity
    • Flint A., Raben A., Ersbøll A. K., Holst J. J., Astrup A., The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. International Journal of Obesity 2001 25 6 781 792 (Pubitemid 32601369)
    • (2001) International Journal of Obesity , vol.25 , Issue.6 , pp. 781-792
    • Flint, A.1    Raben, A.2    Ersboll, A.K.3    Holst, J.J.4    Astrup, A.5
  • 64
    • 0036896243 scopus 로고    scopus 로고
    • The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness
    • Kinzig K. P., D'Alessio D. A., Seeley R. J., The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. Journal of Neuroscience 2002 22 23 10470 10476 2-s2.0-0036896243 (Pubitemid 35416883)
    • (2002) Journal of Neuroscience , vol.22 , Issue.23 , pp. 10470-10476
    • Kinzig, K.P.1    D'Alessio, D.A.2    Seeley, R.J.3
  • 65
    • 47549095688 scopus 로고    scopus 로고
    • Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome
    • DOI 10.1210/jc.2008-0115
    • Elkind-Hirsch K., Marrioneaux O., Bhushan M., Vernor D., Bhushan R., Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2008 93 7 2670 2678 2-s2.0-47549095688 10.1210/jc.2008-0115 (Pubitemid 352008535)
    • (2008) Journal of Clinical Endocrinology and Metabolism , vol.93 , Issue.7 , pp. 2670-2678
    • Elkind-Hirsch, K.1    Marrioneaux, O.2    Bhushan, M.3    Vernor, D.4    Bhushan, R.5
  • 66
    • 70350619609 scopus 로고    scopus 로고
    • Effects of liraglutide in the treatment of obesity: A randomised, double-blind, placebo-controlled study
    • 2-s2.0-70350619609 10.1016/S0140-6736(09)61375-1
    • Astrup A., Rössner S., Van Gaal L., Rissanen A., Niskanen L., Al Hakim M., Madsen J., Rasmussen M. F., Lean M. E., Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. The Lancet 2009 374 9701 1606 1616 2-s2.0-70350619609 10.1016/S0140-6736(09)61375-1
    • (2009) The Lancet , vol.374 , Issue.9701 , pp. 1606-1616
    • Astrup, A.1    Rössner, S.2    Van Gaal, L.3    Rissanen, A.4    Niskanen, L.5    Al Hakim, M.6    Madsen, J.7    Rasmussen, M.F.8    Lean, M.E.9
  • 67
    • 67649666737 scopus 로고    scopus 로고
    • Liraglutide once a day versus exenatide twice a day for type 2 diabetes: A 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
    • 2-s2.0-67649666737 10.1016/S0140-6736(09)60659-0
    • Buse J. B., Rosenstock J., Sesti G., Schmidt W. E., Montanya E., Brett J. H., Zychma M., Blonde L., Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). The Lancet 2009 374 9683 39 47 2-s2.0-67649666737 10.1016/S0140-6736(09)60659-0
    • (2009) The Lancet , vol.374 , Issue.9683 , pp. 39-47
    • Buse, J.B.1    Rosenstock, J.2    Sesti, G.3    Schmidt, W.E.4    Montanya, E.5    Brett, J.H.6    Zychma, M.7    Blonde, L.8
  • 68
    • 77649294607 scopus 로고    scopus 로고
    • Weighing risks and benefits of liraglutide - The FDA's review of a new antidiabetic therapy
    • 2-s2.0-77649294607 10.1056/NEJMp1001578
    • Parks M., Rosebraugh C., Weighing risks and benefits of liraglutide-the FDA's review of a new antidiabetic therapy. New England Journal of Medicine 2010 362 9 774 777 2-s2.0-77649294607 10.1056/NEJMp1001578
    • (2010) New England Journal of Medicine , vol.362 , Issue.9 , pp. 774-777
    • Parks, M.1    Rosebraugh, C.2
  • 70
    • 28744439379 scopus 로고    scopus 로고
    • The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery
    • DOI 10.1210/jc.2005-1490
    • Escobar-Morreale H. F., hescobarm.hrc@salud.madrid.org Botella-Carretero J. I., Álvarez-Blasco F., Sancho J., San Millán J. L., The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. Journal of Clinical Endocrinology and Metabolism 2005 90 12 6364 6369 10.1210/jc.2005-1490 (Pubitemid 41759284)
    • (2005) Journal of Clinical Endocrinology and Metabolism , vol.90 , Issue.12 , pp. 6364-6369
    • Escobar-Morreale, H.F.1    Botella-Carretero, J.I.2    Alvarez-Blasco, F.3    Sancho, J.4    San Millan, J.L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.